Frontlight ResearchEarly access
Gastric and oesophageal cancer trials in United States
274 trials · From ClinicalTrials.gov, checked 19 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peoplePropranolol in Combination With Pembrolizumab and Standard Chemotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Esophageal or Gastroesophageal Junction Adenocarcinoma
- Where
- Buffalo
- Age
- 18 years and over
- People
- 40
- Run by
- Roswell Park Cancer Institute
See details and how to joinNCT05651594 - Phase 1/2Taking peopleA Study of MT-4561 in Patients With Various Advanced Solid Tumors
- Where
- Columbus, Grand Rapids, Houston, Los Angeles
- Age
- 18 years and over
- People
- 27 worldwide
- Run by
- Tanabe Pharma America, Inc.
See details and how to joinNCT06943521 - No phaseTaking peopleExercise Prehabilitation for Locoregional Esophageal Cancer
- Where
- Tampa
- Age
- 18 years and over
- People
- 20
- Run by
- H. Lee Moffitt Cancer Center and Research Institute
See details and how to joinNCT06430346 - Phase 2/3Not yet taking people in United StatesUtidelone Capsule Combined With Fluoropyrimidine- and Platinum-containing Therapy in First-line Treatment of Patients With Gastric or Gastroesophageal Junction Adenocarcinoma
- Where
- Hialeah
- Age
- 18 years and over
- People
- 778 worldwide
- Run by
- Beijing Biostar Pharmaceuticals Co., Ltd.
See details and how to joinNCT06841679 - Phase 2Taking peopleFolfox+Irinotecan+Chemort In Esophageal Cancer
- Where
- Boston, Newton
- Age
- 18 years and over
- People
- 40
- Run by
- Massachusetts General Hospital
See details and how to joinNCT04656041 - No phaseTaking peopleSYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Where
- Albuquerque, Ann Arbor, Atlanta, Aurora, Baltimore, Bethesda, Billings, Birmingham, Boise, Buffalo, Chapel Hill, Charlottesville, Chicago, Cincinnati, Columbus, Dallas, Denver, Duarte, Duluth, Fargo, Greenville, Hartford, Hattiesburg, Hempstead, Houston, Iowa City, Irvine, Jacksonville, Kansas City, La Jolla, Lansing, Little Rock, Littleton, Manhasset, Mayfield Heights, Memphis, Miami, Milwaukee, Mobile, Morgantown, Nashville, Newark, New Brunswick, New Orleans, New York, Norwalk, Omaha, Orange, Philadelphia, Portland, Providence, Salt Lake City, San Francisco, Savannah, Scarborough, Scottsdale, Seattle, Silver Spring, Stanford, Staten Island, St Louis, Tampa, Temple, Towson, Tulsa, Winston-Salem, Worcester
- People
- 50,000 worldwide
- Run by
- Massive Bio, Inc.
See details and how to joinNCT03452774 - No phaseTaking peopleTissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy
- Where
- Chicago
- People
- 1,000
- Run by
- University of Chicago
See details and how to joinNCT01416714 - Phase 1Taking peopleSafety of Combining Irinotecan With 5-FU, Leucovorin/Folinic Acid, Oxaliplatin, and Docetaxel Chemotherapies
- Where
- Chicago
- Age
- 18 years and over
- People
- 54
- Run by
- University of Chicago
See details and how to joinNCT04361708 - Phase 1/2Taking peopleA Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
- Where
- Ann Arbor, Boston, Dallas, Houston, Los Angeles, Nashville
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- LigaChem Biosciences, Inc.
See details and how to joinNCT05941507 - Phase 1Taking peopleA Study of NX-1607 in Adults With Advanced Malignancies
- Where
- Aurora, Chapel Hill, Charlottesville, Chicago, Duarte, Houston, Los Angeles, Oklahoma City, San Francisco, Seattle
- Age
- 18 years and over
- People
- 345 worldwide
- Run by
- Nurix Therapeutics, Inc.
See details and how to joinNCT05107674 - Phase 1/2Taking people64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
- Where
- Cincinnati, Duarte, Grand Rapids, Orange, Stanford
- Age
- 15 years and over
- People
- 26
- Run by
- Lantheus Medical Imaging
See details and how to joinNCT06298916 - Phase 2Taking peopleAPL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Where
- Boston, Chapel Hill, Hershey, Los Angeles, Madison, Tampa
- Age
- 18 years and over
- People
- 497 worldwide
- Run by
- Apollomics Inc.
See details and how to joinNCT03175224 · EU 2024-514542-37-00 - No phaseTaking peopleNonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux
- Where
- Cleveland
- Age
- 40 years to 85 years
- People
- 400
- Run by
- Louis Stokes VA Medical Center
See details and how to joinNCT06746623 - Phase 1Taking peopleIntra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors
- Where
- Pittsburgh
- Age
- 18 years to 69 years
- People
- 18
- Run by
- Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
See details and how to joinNCT07001592 - Phase 1/2Taking peopleRAPA-201 Therapy of Solid Tumors
- Where
- Hackensack
- Age
- 18 years and over
- People
- 37
- Run by
- Rapa Therapeutics LLC
See details and how to joinNCT05144698 - No phaseEnrolling by invitationStudy to Evaluate EnteroTracker® as a Sampling Method to Screen for Barrett's Esophagus/Esophageal Cancer
- Where
- Aurora
- Age
- 45 years and over
- People
- 60
- Run by
- University of Colorado, Denver
See details and how to joinNCT05706025 - No phaseTaking peopleA Multicenter Cancer Biospecimen Collection Study
- Where
- San Francisco
- Age
- 18 years and over
- People
- 1,650
- Run by
- Cofactor Genomics, Inc.
See details and how to joinNCT04510129 - No phaseTaking peopleTREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus)
- Where
- Chicago, Los Angeles, St Louis, Tampa
- Age
- 18 years to 100 years
- People
- 5,000
- Run by
- University of Colorado, Denver
See details and how to joinNCT02634645 - Phase 1Not yet taking people in United StatesEPITOME-1015-I: a Study to Investigate the Safety and Tolerability of MDG1015 in Patients with Epithelial Ovarian Cancer, Gastroesophageal Adenocarcinoma, Round Cell Liposarcoma And/or Synovial Sarcoma
- Where
- Seattle
- Age
- 18 years and over
- People
- 55 worldwide
- Run by
- Medigene AG
See details and how to joinNCT06748872 · EU 2024-516787-28-00 - No phaseTaking peopleComprehensive Outcomes for After Cancer Health
- Where
- Boston, Columbus, Gainesville, Houston, New York, Omaha
- Age
- 18 years and over
- People
- 625
- Run by
- Pack Health
See details and how to joinNCT05349227 - No phaseTaking peoplePatient Preferences for Barrett's Esophagus and Esophageal Cancer Screening Tests
- Where
- Aurora
- Age
- 18 years to 89 years
- People
- 556
- Run by
- University of Colorado, Denver
See details and how to joinNCT06693622 - Phase 2Not yet taking people in United StatesThe Efficacy of PIPAC and Minimally Invasive Radical Resection in High-risk Gastric Cancer Patients.
- Where
- Duarte
- Age
- 18 years to 80 years
- People
- 264 worldwide
- Run by
- Odense University Hospital
See details and how to joinNCT06295094 - No phaseTaking peopleDistribution of Lymph Node Metastases in Esophageal Carcinoma
- Where
- Houston
- Age
- 18 years and over
- People
- 5,000 worldwide
- Run by
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
See details and how to joinNCT03222895 - Phase 2Taking peopleCPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors
- Where
- Chicago
- Age
- 18 years and over
- People
- 94
- Run by
- Northwestern University
See details and how to joinNCT05733000